Current Ratio of iTeos Therapeutics, Inc. from 31 Mar 2021 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
iTeos Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2021 to 30 Jun 2025.
  • iTeos Therapeutics, Inc. Current Ratio for the quarter ending 30 Jun 2025 was 1143%, a 30% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

iTeos Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2025 1143% -501% -30% 30 Jun 2025
Q1 2025 1480% -212% -13% 31 Mar 2025
Q4 2024 1466% -459% -24% 31 Dec 2024
Q3 2024 1498% -459% -23% 30 Sep 2024
Q2 2024 1644% +278% +20% 30 Jun 2024
Q1 2024 1692% +713% +73% 31 Mar 2024
Q4 2023 1926% +1227% +176% 31 Dec 2023
Q3 2023 1957% +1485% +315% 30 Sep 2023
Q2 2023 1367% +1067% +356% 30 Jun 2023
Q1 2023 980% +697% +247% 31 Mar 2023
Q4 2022 699% +423% +153% 31 Dec 2022
Q3 2022 471% +151% +47% 30 Sep 2022
Q2 2022 300% -1979% -87% 30 Jun 2022
Q1 2022 282% -2294% -89% 31 Mar 2022
Q4 2021 276% 31 Dec 2021
Q3 2021 320% 30 Sep 2021
Q2 2021 2279% 30 Jun 2021
Q1 2021 2576% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.